Delivery Order SPE2DB22D1202-SPE2DB24FVBH0
Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $5,262.17, is a Delivery Order contract with a firm fixed price pricing type. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,988.96 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a completion date of June 12, 2024. This Delivery Order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a firm fixed price of $1,526.34 and a completion date of June 12, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML pharmaceutical products. The $2,567.03 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,264.14 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, to the U.S. government. The award, valued at $33,413.79, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) worth up to...
- The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML with a firm fixed price of $4,611.36. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of November 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC encompasses a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. The $4,067.19 firm fixed price contract was awarded by the Medical Supply Chain division of the Department of Defense. The contract has an ultimate completion date of July 12, 2024 and was awarded on July 11, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the medication AIMOVIG 140 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The contract, valued at $1,050.38, is a firm-fixed price delivery order with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FVBH0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,088.07 delivery order is under a larger, single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which expires on December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 8/22/24, 2:56 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 5/23/24 |